| Literature DB >> 34979073 |
Prasanth Manohar1,2, Madhav Madurantakam Royam3, Belinda Loh1, Bulent Bozdogan4, Ramesh Nachimuthu3, Sebastian Leptihn1,5,6.
Abstract
Non-antibiotic alternative treatments to combat the increasing number of infections caused by multidrug resistant bacteria are urgently needed. In recent years, bacteriophages have reemerged to potentially replace or complement the role of antibiotics, as bacterial viruses have the ability to inactivate pathogens. This study aimed to evaluate the synergy of phage-antibiotic combinations. A Citrobacter amalonaticus isolate was used in this study together with the phage MRM57. Eight different antibiotics with different mechanisms of action were used in combination with the phage to study the impact of the combination treatment on the minimal inhibitory concentrations. We found that antibiotic concentration dependent synergism exists, albeit at different extents, with very low numbers of phages. This demonstrates the use of phages as an adjuvant with a sublethal concentration of antibiotics as an effective therapeutic strategy.Entities:
Keywords: Citrobacter spp.; Phage therapy; bacteriophage; fractional inhibitory concentration; phage−antibiotic synergy; synergistic effect
Mesh:
Substances:
Year: 2022 PMID: 34979073 DOI: 10.1021/acsinfecdis.1c00117
Source DB: PubMed Journal: ACS Infect Dis ISSN: 2373-8227 Impact factor: 5.084